Post Views: 185 In the year 2020, an estimate of 2.2 million people has been diagnosed with lung cancer. It is the second most commonly diagnosed cancer and is among leading cause…
Search Results for: lung cancer patients
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
Post Views: 197 The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumors express…
Topotecan–Berzosertib Combination Effective for SCLC Treatment
Post Views: 272 Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of lung cancer: small cell lung…
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Post Views: 570 Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United States. Also, approximately…
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
Post Views: 399 National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for first-line treatment of non-small cell lung cancer (NSCLC). This…
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
Post Views: 470 The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or…
Researchers Identify Protein to Signal if NSCLC will Spread
Post Views: 596 Lung cancer is one of the deadliest cancers in men and women worldwide. The most prevalent form of lung cancer is non-small cell lung cancer (NSCLC). NSCLC tumors are…
Drug: Gemcitabine Hydrochloride to Treat NSCLC
Post Views: 1,341 Gemcitabine belongs to the group of cancer-fighting medications called antineoplastics. Gemcitabine Hydrochloride is a novel anti-cancer drug and is marketed as an indication of non-small cell lung cancer. It…
Drug: Tagrisso (Osimertinib) to Treat NSCLC
Post Views: 1,642 Osimertinib or Tagrisso is an FDA-approved drug by FDA as a frontline treatment for patients with non-small cell lung cancer (NSCLC). It is indicated for the first-line lung cancer…
Drug: Nivolumab to Treat NSCLC
Post Views: 1,750 About Nivolumab Nivolumab or Opdivo is a prescription drug used for the treatment of advanced non-small cell lung cancer. It is given to those patients where lung cancer has…
Drug: Paclitaxel to Treat NSCLC
Post Views: 1,519 In the past two decades, little progress has been made in the field of lung cancer treatment. Patients with advanced level of cancer find it difficult to survive. Non-small…
Drug: Hycamtin (Topotecan Hydrochloride) to Treat SCLC
Post Views: 2,071 Small Cell Lung Cancer is caused by uncontrolled proliferation of cells and it can spread throughout the body. It is commonly caused by smoking and the other factors include…